US2014324025A1PendingUtilityA1
Devices and methods for delivering active agents to the osteomeatal complex
Est. expiryJul 10, 2026(expired)· nominal 20-yr term from priority
Inventors:Patrick A. ArensdorfDanielle L. BiggsRodney BrennemanDavid B. DownieDonald J. EatonThomas R. Tice
A61L 31/148A61L 31/08A61P 43/00A61L 31/16A61M 31/00A61K 9/0043
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described here are devices, methods, and kits for treating sinusitis and related respiratory conditions by locally delivering active agents to the osteomeatal complex over a sustained period of time. The devices may be passively fixed within the osteomeatal complex and/or include one or more features that actively fix it within the osteomeatal complex. The devices may optionally include a portion that extends into a sinus ostium, sinus cavity, and/or the nasal passage to deliver an active agent.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for cannulating a portion of an osteomeatal complex comprising:
securing a portion of a cannulating device to the osteomeatal complex by piercing a portion of the osteomeatal complex with a pointed tip of the cannulating device, wherein the cannulating device comprises a lumen extending at least partially therethrough.
2 . The method of claim 1 wherein the cannulating device is configured to release one or more active agents.
3 . The method of claim 2 wherein the one or more active agents comprises an anti-inflammatory agent.
4 . The method of claim 3 wherein the anti-inflammatory agent comprises mometasone furoate.
5 . The method of claim 3 wherein the anti-inflammatory agent comprises fluticasone propionate.
6 . The method of claim 1 wherein the cannulating device comprises a polymer coating.
7 . The method of claim 6 wherein the polymer coating comprises one or more active agents.
8 . The method of claim 1 wherein the cannulating device comprises a biodegradable polymer.
9 . The method of claim 8 wherein the biodegradable polymer comprises a lactide/glycolide polymer.
10 . The method of claim 1 wherein piercing the portion of the osteomeatal complex comprises piercing an ethmoid bulla.
11 . The method of claim 1 wherein piercing the portion of the osteomeatal complex comprises piercing an anterior ethmoid cell.
12 . The method of claim 1 wherein the cannulating device comprises a plurality of openings in a side of the cannulating device, wherein the openings are connected to the lumen.
13 . The method of claim 1 wherein piercing a portion of the osteomeatal complex comprises piercing an ethmoid bulla and a septum between the ethmoid bulla and an anterior ethmoid cell to create a channel between the ethmoid bulla and the anterior ethmoid cell.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.